Gs – Lonza

Class 1Cells for scientific, laboratory and medical research and for clinical usage, including genetic material for the production of proteins; biological preparations, especially genetically modified cells and vectors for the production of human, animal and synthetic proteins, for clinical and commercial purposes for human and animal therapies, for clinical and commercial use in scientific research and for use in pharmaceutical research; kits consisting of cell lines, reagents, enzyme substrates and/or genetically modified chemical preparations; reagents, nucleic acids and nucleotides for scientific use and for research purposes in the field of clinical research, drug development, research in agriculture and genetics; reagent kits consisting of reagents and chemical preparations; samples of nucleotide sequence variants and modifications for use in the field of scientific research, clinical research and scientific research in diagnosis.

Class 5Biological preparations, namely genetically modified cells and genetically modified vectors for production of human, animal and synthetic proteins, for medicinal purposes and for clinical and commercial use in human and animal therapy; gene therapy products, namely, modified cells and modified cell platforms.

Class 40Manufacturing services for the benefit of third parties, of genetically modified cells and carriers for the production of human, animal and synthetic proteins, for clinical and commercial use, in scientific research and in pharmaceutical research as well as for clinical and commercial purposes in human and animal therapy, all services upon request and according to the specifications of third parties.

Class 42Scientific and medical research in the field of biotechnology; technical consultancy and project planning in the field of biological research relating to proteins; research and development in the field of proteins for others; scientific research and laboratory services in the fields of editing, modification, engineering and regulation of genes, genome and cells for the development of pharmaceutical and biological preparations for human and veterinary use; aggregating, analyzing and providing data in the field of genomics; customized design and development of cell lines intended for third parties for scientific research, discovery and drug development purposes; scientific research and laboratory services in the fields of editing, modification, engineering and regulation of genes, genome and cells for the development of medical diagnostic products.